1. FDA approves first interchangeable biosimilar —AstraZeneca still eyes US vaccine filing despite another delay -- AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA See more on our front page news
    Dismiss Notice
  2. Do you have general questions about dealing with sexual harassment or discrimination at work? Ask an attorney on this forum.
    Dismiss Notice

Reply to Thread

Verification:

(CustomImgCaptcha By Surrey Forum)